BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 1341991)

  • 41. Hormonal side effects in women: typical versus atypical antipsychotic treatment.
    Dickson RA; Seeman MV; Corenblum B
    J Clin Psychiatry; 2000; 61 Suppl 3():10-5. PubMed ID: 10724128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperprolactinemia after low dose of amisulpride.
    Kopecek M; Bares M; Svarc J; Dockery C; Horácek J
    Neuro Endocrinol Lett; 2004 Dec; 25(6):419-22. PubMed ID: 15665803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.
    Misra M; Papakostas GI; Klibanski A
    J Clin Psychiatry; 2004 Dec; 65(12):1607-18; quiz 1590, 1760-1. PubMed ID: 15641865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis and management of galactorrhea.
    Leung AK; Pacaud D
    Am Fam Physician; 2004 Aug; 70(3):543-50. PubMed ID: 15317441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option.
    Rusgis MM; Alabbasi AY; Nelson LA
    Am J Health Syst Pharm; 2021 May; 78(10):862-871. PubMed ID: 33954421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antipsychotic-induced hyperprolactinaemia.
    Inder WJ; Castle D
    Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drugs and prolactin.
    Molitch ME
    Pituitary; 2008; 11(2):209-18. PubMed ID: 18404390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hyperprolactinemia in mentally ill patients].
    Carvalho MM; Góis C
    Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).
    Kelly DL; Wehring HJ; Earl AK; Sullivan KM; Dickerson FB; Feldman S; McMahon RP; Buchanan RW; Warfel D; Keller WR; Fischer BA; Shim JC
    BMC Psychiatry; 2013 Aug; 13():214. PubMed ID: 23968123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aripiprazole for the treatment of duloxetine-induced hyperprolactinemia: A case report.
    Luo T; Liu QS; Yang YJ; Wei B
    J Affect Disord; 2019 May; 250():330-332. PubMed ID: 30875676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation and management of galactorrhea.
    Huang W; Molitch ME
    Am Fam Physician; 2012 Jun; 85(11):1073-80. PubMed ID: 22962879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Verapamil-induced hyperprolactinemia--a case report].
    Krysiak R; Okopieh B; Herman ZS
    Pol Arch Med Wewn; 2005 Feb; 113(2):155-8. PubMed ID: 16209236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Galactorrhea].
    Iino Y; Mori H
    Nihon Rinsho; 1997 Nov; 55(11):2914-9. PubMed ID: 9396287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gynecologic and reproductive health concerns of adolescents using selected psychotropic medications.
    Talib HJ; Alderman EM
    J Pediatr Adolesc Gynecol; 2013 Feb; 26(1):7-15. PubMed ID: 22929762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pituitary production of prolactin and prolactin-suppressing drugs.
    Tansey MJ; Schlechte JA
    Lupus; 2001; 10(10):660-4. PubMed ID: 11721691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparing the Effectiveness and Safety of the Addition of and Switching to Aripiprazole for Resolving Antipsychotic-Induced Hyperprolactinemia: A Multicenter, Open-Label, Prospective Study.
    Yoon HW; Lee JS; Park SJ; Lee SK; Choi WJ; Kim TY; Hong CH; Seok JH; Park IH; Son SJ; Roh D; Kim BR; Lee BO
    Clin Neuropharmacol; 2016; 39(6):288-294. PubMed ID: 27438182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.
    Besag FMC; Vasey MJ; Salim I
    CNS Drugs; 2021 May; 35(5):507-526. PubMed ID: 33880739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of cabergoline in the management of pituitary prolactin-induced symptoms with patients treated with atypical neuroleptics.
    Coronas R; Cobo J; Giménez-Palop O; Ortega E; Márquez M
    Curr Drug Saf; 2012 Apr; 7(2):92-8. PubMed ID: 22873493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Olanzapine-induced hyperprolactinemia and galactorrhea reversed with addition of bromocriptine: a case report.
    Miller DE; Sebastian CS
    J Clin Psychiatry; 2005 Feb; 66(2):269-70. PubMed ID: 15705020
    [No Abstract]   [Full Text] [Related]  

  • 60. Prolactin and antipsychotic medications: mechanism of action.
    Petty RG
    Schizophr Res; 1999 Mar; 35 Suppl():S67-73. PubMed ID: 10190227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.